Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Redox-Driven Blood-Nerve Barrier Dysfunction in Diabetic Peripheral Neuropathy: Mechanisms and Therapeutic Opportunities
Antioxidants (Basel, Switzerland), 2026;15(6)
Benefits of Incretin Therapy on Ovarian Function: A Scientific Literature Review
International journal of molecular sciences, 2026;27(11)
Impact of GLP-1 Receptor Agonists on Chronic Low Back Pain in Patients with Obesity: A Prospective Pilot Cohort Study
medRxiv : the preprint server for health sciences, 2026
Type B insulin resistance with glycemic extremes: a case report and literature review
Frontiers in endocrinology, 2026;17:1852784
GLP-1 Receptor Agonists and Dual GIP/GLP-1 Receptor Agonists in Children and Adolescents with Obesity: Clinical Outcomes and the Impact of Nutritional and Behavioral Co-Interventions-A Systematic Review
Nutrients, 2026;18(11)
Retrospective Comparative Study of Oral Versus Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus
International journal of molecular sciences, 2026;27(11)
Recombinant Human Thymosin β4 Attenuates Endotoxemia-Induced ALI and EAE by Suppressing Inflammatory and Oxidative Responses
Biomolecules, 2026;16(6)
Association of Tirzepatide versus Glucagon-Like Peptide-1 Receptor Agonists with Incident Glaucoma in Patients with Type 2 Diabetes: A Retrospective Cohort Study
Ophthalmology science, 2026;6(7):101245
Glucagon-like peptide-1 receptor agonist, semaglutide, attenuates intravenous self-administration of fentanyl in female rats
bioRxiv : the preprint server for biology, 2026
Tirzepatide and Cardiometabolic Effects in Obese Non-diabetic Adults: A Systematic Review, Meta-Analysis, and Narrative Synthesis of Cardiovascular Outcomes
Cureus, 2026;18(5):e109350
BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers
Pharmaceutics, 2026;18(5)
A rationally designed 18-amino acid peptide with potential as GLP-1 receptor agonist
Frontiers in pharmacology, 2026;17:1789257
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
JBJS reviews, 2026;14(5)
Clinical impact of tirzepatide on patients with chronic obstructive pulmonary disease
Frontiers in pharmacology, 2026;17:1838392
Psychosocial Outcomes in Telemedicine and Long-Acting Incretin-Specific Behavioral Intervention
Obesity science & practice, 2026;12(3):e70149
Efficacy and safety of novel formulation of semaglutide injection: A multicentre, randomized, comparative, active controlled, phase 3 study in comparison with reference biologic in Indian patients with type 2 diabetes mellitus
Metabolism open, 2026;30:100476
Corrigendum to “Efficacy and safety of semaglutide injection in comparison with reference semaglutide for chronic weight management in Indian adults with obesity: A phase III randomized non-inferiority trial” [Metabol Open 30 (2026) 100460]
Metabolism open, 2026;30:100477
A Case of an Invisible Pancreatic Neuroendocrine Tumor Decoded by Endoscopic Ultrasound
Cureus, 2026;18(5):e109296
Comparative effectiveness of tirzepatide versus GLP-1 receptor agonists on the risk of venous thromboembolism in patients with obesity: a real-world cohort study
Frontiers in medicine, 2026;13:1820366
Swiss obesity clinical practice guidance
Swiss medical weekly, 2026;156:5415